| pubmed-article:21304210 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:21304210 | lifeskim:mentions | umls-concept:C0007194 | lld:lifeskim |
| pubmed-article:21304210 | lifeskim:mentions | umls-concept:C0054015 | lld:lifeskim |
| pubmed-article:21304210 | lifeskim:mentions | umls-concept:C0242485 | lld:lifeskim |
| pubmed-article:21304210 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
| pubmed-article:21304210 | lifeskim:mentions | umls-concept:C1305957 | lld:lifeskim |
| pubmed-article:21304210 | lifeskim:mentions | umls-concept:C0205195 | lld:lifeskim |
| pubmed-article:21304210 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:21304210 | pubmed:dateCreated | 2011-3-28 | lld:pubmed |
| pubmed-article:21304210 | pubmed:abstractText | Although serum cardiac troponin I (cTnI) and plasma brain natriuretic peptide (BNP) have become clinically important tools as diagnostic and prognostic markers for ischemic heart disease and heart failure, the usefulness of these biomarkers for risk stratification of hypertrophic cardiomyopathy (HCM) is not clear. | lld:pubmed |
| pubmed-article:21304210 | pubmed:language | eng | lld:pubmed |
| pubmed-article:21304210 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21304210 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:21304210 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21304210 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21304210 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21304210 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:21304210 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:21304210 | pubmed:issn | 1347-4820 | lld:pubmed |
| pubmed-article:21304210 | pubmed:author | pubmed-author:KitaokaHiroak... | lld:pubmed |
| pubmed-article:21304210 | pubmed:author | pubmed-author:KuboToruT | lld:pubmed |
| pubmed-article:21304210 | pubmed:author | pubmed-author:SugiuraTetsur... | lld:pubmed |
| pubmed-article:21304210 | pubmed:author | pubmed-author:YasudaNobufum... | lld:pubmed |
| pubmed-article:21304210 | pubmed:author | pubmed-author:MatsumuraYosh... | lld:pubmed |
| pubmed-article:21304210 | pubmed:author | pubmed-author:YamasakiNaohi... | lld:pubmed |
| pubmed-article:21304210 | pubmed:author | pubmed-author:OkawaMakotoM | lld:pubmed |
| pubmed-article:21304210 | pubmed:author | pubmed-author:YamanakaShige... | lld:pubmed |
| pubmed-article:21304210 | pubmed:author | pubmed-author:DoiYoshinori... | lld:pubmed |
| pubmed-article:21304210 | pubmed:author | pubmed-author:BabaYuichiY | lld:pubmed |
| pubmed-article:21304210 | pubmed:author | pubmed-author:HirotaTakayos... | lld:pubmed |
| pubmed-article:21304210 | pubmed:author | pubmed-author:HayatoKayoK | lld:pubmed |
| pubmed-article:21304210 | pubmed:copyrightInfo | All rights are reserved to the Japanese Circulation Society. | lld:pubmed |
| pubmed-article:21304210 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:21304210 | pubmed:volume | 75 | lld:pubmed |
| pubmed-article:21304210 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:21304210 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:21304210 | pubmed:pagination | 919-26 | lld:pubmed |
| pubmed-article:21304210 | pubmed:meshHeading | pubmed-meshheading:21304210... | lld:pubmed |
| pubmed-article:21304210 | pubmed:meshHeading | pubmed-meshheading:21304210... | lld:pubmed |
| pubmed-article:21304210 | pubmed:meshHeading | pubmed-meshheading:21304210... | lld:pubmed |
| pubmed-article:21304210 | pubmed:meshHeading | pubmed-meshheading:21304210... | lld:pubmed |
| pubmed-article:21304210 | pubmed:meshHeading | pubmed-meshheading:21304210... | lld:pubmed |
| pubmed-article:21304210 | pubmed:meshHeading | pubmed-meshheading:21304210... | lld:pubmed |
| pubmed-article:21304210 | pubmed:meshHeading | pubmed-meshheading:21304210... | lld:pubmed |
| pubmed-article:21304210 | pubmed:meshHeading | pubmed-meshheading:21304210... | lld:pubmed |
| pubmed-article:21304210 | pubmed:meshHeading | pubmed-meshheading:21304210... | lld:pubmed |
| pubmed-article:21304210 | pubmed:meshHeading | pubmed-meshheading:21304210... | lld:pubmed |
| pubmed-article:21304210 | pubmed:meshHeading | pubmed-meshheading:21304210... | lld:pubmed |
| pubmed-article:21304210 | pubmed:meshHeading | pubmed-meshheading:21304210... | lld:pubmed |
| pubmed-article:21304210 | pubmed:meshHeading | pubmed-meshheading:21304210... | lld:pubmed |
| pubmed-article:21304210 | pubmed:meshHeading | pubmed-meshheading:21304210... | lld:pubmed |
| pubmed-article:21304210 | pubmed:meshHeading | pubmed-meshheading:21304210... | lld:pubmed |
| pubmed-article:21304210 | pubmed:year | 2011 | lld:pubmed |
| pubmed-article:21304210 | pubmed:articleTitle | Combined measurements of cardiac troponin I and brain natriuretic peptide are useful for predicting adverse outcomes in hypertrophic cardiomyopathy. | lld:pubmed |
| pubmed-article:21304210 | pubmed:affiliation | Department of Medicine and Geriatrics, Kochi Medical School, Nankoku, Japan. | lld:pubmed |
| pubmed-article:21304210 | pubmed:publicationType | Journal Article | lld:pubmed |
| entrez-gene:4879 | entrezgene:pubmed | pubmed-article:21304210 | lld:entrezgene |
| entrez-gene:7137 | entrezgene:pubmed | pubmed-article:21304210 | lld:entrezgene |
| http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:21304210 | lld:entrezgene |
| http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:21304210 | lld:entrezgene |
